US FDA grants Orphan Drug Designation to Atossa Therapeutics’ (Z)-endoxifen to treat Duchenne muscular dystrophy: Seattle Monday, January 19, 2026, 17:00 Hrs [IST] Atossa Therap ...
European Commission approves Sobi’s Aspaveli for the treatment of C3G and primary IC-MPGN: Stockholm Monday, January 19, 2026, 10:00 Hrs [IST] Sobi, a global biopharma company u ...
A Portland, Oregon, baby got sick with infant botulism after drinking contaminated ByHeart formula donated through a program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback